Colorectal cancer screening
- First Online:
Colorectal cancer (CRC) constitutes the second leading cause of death from cancer in the United States. Increased screening for CRC have been associated with a decreased incidence in the past two decades. Continued efforts are necessary to maintain this trend. Appropriate risk stratification of individuals and compliance with recommended screening strategies are important. Colonoscopy continues to play an important role in screening; however, several different screening options are available for average-risk individuals. This article reviews the current options open to physicians to adequately screen patients for CRC based on inherit risks.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 3.SEER Cancer Statistics Review, 1975–2004. Edited by Ries L, Melbert D, Krapcho M, et al.: Bethesda, MD: National Cancer Institute; 2007.Google Scholar
- 14.Wilson JG, Junger G: Principals and Practice of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968.Google Scholar
- 19.Smith A, Young GP, Cole SR, et al.: Comparison of a crushsampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006, 107:2151–2159.Google Scholar
- 21.Levin B, Lieberman DA, McFarland B, et al.: Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force of Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008, 58:130–160.CrossRefPubMedGoogle Scholar
- 25.Byers T, Levin B, Rothenberger D, et al.: American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997, 47:154–160.CrossRefPubMedGoogle Scholar
- 29.Fork FT, Lindstrom C, Ekelund G: Double contrast examination in carcinoma of the colon and rectum. A prospective clinical series. Acta Radiol Diagn (Stockh) 1983, 24:177–188.Google Scholar
- 39.Bresslet B, Paszat LF, Vinden C, et al.: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003, 95:230–236.Google Scholar
- 43.Burt RQ, Barthel JS, David DS, et al.: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology; Colorectal Cancer Screening. Version 2, 2008.Google Scholar
- 45.Surveillance Epidemiology and End Results: SEER Cancer Statistics Review, 1975–2000. Edited by Rise LAG, Eisner MP, Kosary CL, et al. Bethesda, MD: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2000. Accessed August 2009.
- 51.. Centers for Disease Control and Prevention (CDC): Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep, 2008:57:253–258.Google Scholar